A critical comparison of three internalization assays applied to the evaluation of a given mAb as a toxin-carrier candidate
暂无分享,去创建一个
S. Ménard | S. Canevari | M. Gadina | D. Mezzanzanica | P. Casalini | M. Colnaghi | M. Caldera | E. Tosi
[1] S. Ménard,et al. p185 HER2/neu epitope mapping with murine monoclonal antibodies. , 1992, Hybridoma.
[2] S. Ménard,et al. Glycolipids carrying Ley are preferentially expressed on small‐cell lung cancer cells as detected by the monoclonal antibody MLuC1 , 1992, International journal of cancer.
[3] R. G. Anderson,et al. Potocytosis: sequestration and transport of small molecules by caveolae. , 1992, Science.
[4] V. Zurawski,et al. Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein. , 1991, Cancer research.
[5] Wawrzynczak Ej. Systemic immunotoxin therapy of cancer: advances and prospects. , 1991 .
[6] E. Wawrzynczak,et al. Monoclonal antibodies recognising the cluster 2 antigen associated with human small cell lung cancer mediate the toxic effects of ricin A chain in an indirect assay of immunotoxin cytotoxicity. , 1991, The British journal of cancer. Supplement.
[7] S. Canevari,et al. Use of combination of monoclonal antibodies directed against three distinct epitopes of a tumor‐associated antigen: Analysis of cell binding and internalization , 1991, International journal of cancer.
[8] S. Canevari,et al. Preparation and biological characterization of conjugates consisting of ricin and a tumor-specific non-internalizing MAb. , 1991, Anticancer research.
[9] R. Chignola,et al. Distribution of endocytosed molecules to intracellular acidic environments correlates with immunotoxin activity , 1990, International journal of cancer.
[10] S. Canevari,et al. Fractionation of the ribosome inactivating protein preparations with triazine dyes. , 1990, Biochemical and biophysical research communications.
[11] A. Harris. The epidermal growth factor receptor as a target for therapy. , 1990, Cancer cells.
[12] A. Ullrich,et al. Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor or HER2/neu gene product. , 1990, Cancer research.
[13] T. Yamaguchi,et al. Antigenic modulation and internalization of monoclonal antibody to human colonic carcinoma cells detected by enzyme‐linked immunosorbent assay , 1989, International journal of cancer.
[14] I. Gigli,et al. Endocytosis and shedding of the decay accelerating factor on human polymorphonuclear cells. , 1989, Journal of immunology.
[15] S. Watkins,et al. Cytotoxicity of gelonin and its conjugates with antibodies is determined by the extent of their endocytosis , 1989, Journal of cellular physiology.
[16] R. Reisfeld,et al. Rate of internalization of an immunotoxin correlates with cytotoxic activity against human tumor cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[17] K. Foon. Biological response modifiers: the new immunotherapy. , 1989, Cancer research.
[18] S. Canevari,et al. The Aspergillus toxin restrictocin is a suitable cytotoxic agent for generation of immunoconjugates with monoclonal antibodies directed against human carcinoma cells , 1989 .
[19] O. Petersen,et al. Immunotoxins--entry into cells and mechanisms of action. , 1989, Immunology today.
[20] E. Yunis,et al. Receptor-like nature of class I HLA: endocytosis via coated pits. , 1988, Journal of immunology.
[21] J. Calafat,et al. Endocytosis and intracellular routing of an antibody-ricin A chain conjugate. , 1988, Cancer research.
[22] O. Fodstad,et al. New indirect approach to the therapeutic use of immunotoxins. , 1988, Journal of the National Cancer Institute.
[23] R. Youle. Fatal attraction in vitro and in vivo. , 1988, Journal of the National Cancer Institute.
[24] J. Uhr,et al. An assay that predicts the ability of monoclonal antibodies to form potent ricin A chain-containing immunotoxins. , 1988, Cancer research.
[25] J. Weltman,et al. Rapid screening with indirect immunotoxin for monoclonal antibodies against human small cell lung cancer. , 1987, Cancer research.
[26] M. Herlyn,et al. Presence of tumor-associated antigens in epidermal growth factor receptors from different human carcinomas. , 1987, Cancer research.
[27] S. Canevari,et al. Internalization of a monoclonal antibody against human breast cancer by immunoelectron microscopy. , 1987, British Journal of Cancer.
[28] S. Ménard,et al. Characterization of human ovarian carcinoma‐associated antigens defined by novel monoclonal antibodies with tumor‐restricted specificity , 1987, International journal of cancer.
[29] S. Warnaar. Selection of Monoclonal Antibodies. , 1987 .
[30] I. Pastan,et al. Immunotoxins , 1986, Cell.
[31] Baldwin Rw,et al. Endocytosis of a monoclonal antibody recognising a cell surface glycoprotein antigen visualised using fluorescent conjugates. , 1986 .
[32] E. Bröcker,et al. Modes of binding and internalization of monoclonal antibodies to human melanoma cell lines. , 1986, Cancer research.
[33] R. W. Baldwin,et al. Endocytosis of a monoclonal antibody recognising a cell surface glycoprotein antigen visualised using fluorescent conjugates. , 1986, European journal of cell biology.
[34] S. Ménard,et al. Generation of monoclonal antibodies reacting with normal and cancer cells of human breast. , 1983, Cancer research.
[35] C. Jenkin,et al. Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose. , 1978, Immunochemistry.
[36] C. Milstein,et al. Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.
[37] J. Marchalonis. An enzymic method for the trace iodination of immunoglobulins and other proteins. , 1969, The Biochemical journal.